Stock listing

Personalis, Inc.

Selected listing: A2PLTK · LSX · EUR · DE

Personalis, Inc. (LS Exchange: A2PLTK), Health Services. Latest release Aug 4, 2026: Personalis Reports Second Quarter Results and Recent Highlights.

A2PLTK:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A2PLTK
Asset type: Stock
Sector: Health Services
Industry: Medical/Nursing Services
Exchange: LS Exchange
Currency: EUR

About Personalis, Inc.

Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.

Latest news from Personalis, Inc.

Personalis Reports Second Quarter Results and Recent Highlights

August 4, 2026

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

July 20, 2026

Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain

July 14, 2026

Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits

June 9, 2026

Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026

June 2, 2026

All Personalis, Inc. news →

Events

Replays

Personalis, Inc. (PSNL) Q1 2026 Earnings Call
Thu, May 07, 2026 · 05:00 PM ET
Watch
Personalis, Inc. (PSNL) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 05:00 PM ET
Watch
Personalis, Inc. (PSNL) Q1 2025 Earnings Call
Tue, May 06, 2025 · 05:00 PM ET
Watch

Research Personalis, Inc.

Personalis, Inc. company profile

View the public company page for Personalis, Inc. on 6ix.

Personalis, Inc. news

Read company news and market updates connected to Personalis, Inc..

Personalis, Inc. investor events

Find investor webinars, events, and replay context for Personalis, Inc..